Recently, we hypothesized that the tumour-suppressive, human helper-virus-dependent, adenoassociated parvoviruses (AAV) may interfere with transforming functions of human papillomaviruses (HPV) in the development of cervical carcinoma. Here, we demonstrate that in cervical epithelium containing papillomavirus DNA, AAV DNA can be detected in a replication-competent form and that AAV proteins are expressed. In cultured cells con-
Introduction
Specific types of human papillomaviruses (HPV ; notably HPV type 16) are causally linked to cervical intraepithelial lesions and anogenital cancer (zur Hausen, 1987 (zur Hausen, , 1991 Mun4 oz et al., 1994) .
Recent results revealed the presence of DNA of the human helper-virus-dependent parvovirus, adeno-associated virus type 2 (AAV-2), in biopsies of the uterine mucosa and the uterine cervix of the majority of women (Tobiasch et al., 1994) . Furthermore, AAV-5 has been isolated from a genital site (Bantel-Schaal & zur Hausen, 1984) . For its replication, AAV normally requires functions provided by helper viruses such as adenoviruses, herpesviruses (Berns & Bohensky, 1987) or vaccinia virus (Schlehofer et al., 1986) , or cellular factors induced by genotoxic stress (reviewed in Schlehofer, 1994) . AAV is known to insert its DNA into the host cell genome in the absence of helper viruses (at least in cell culture) (Kotin et al., 1990 ; Samulski, 1993 ; Walz & Schlehofer, 1992) , and has been shown to exert tumour-suppressive properties in vitro and in vivo (reviewed in Schlehofer, 1994) . Serological data have shown that cervical carcinoma patients less frequently exhibit antibodies to AAV than matched control women, indicating a somewhat protective effect of AAV infection (Georg-Fries et al., 1984 ; Mayor et al., 1976) . This is supported by reports on interference of AAV-2 early (rep) proteins with the transforming functions of bovine papillomavirus (BPV) or HPV-16 (Hermonat, 1989 (Hermonat, , 1994 . In addition, theoretical analyses suggest that AAV may influence the pathogenic potential of other viruses including protection from malignant transformation (Mayor, 1993) .
These findings prompted us to analyse in vitro a possible interaction of the two viruses. Here we report that in cervical biopsies, AAV-2 and HPV-16 are co-localized, that expression of HPV-16 genes in combination with AAV-2 genes leads to an interaction of the two viruses resulting in a cytopathic effect (CPE) and induction of AAV-2 replication. In addition, AAV-2 was found to be rescuable from an integrated stage after transfection with HPV-16 DNA.
The results demonstrate for the first time that HPV-16 can provide helper-virus functions for AAV-2 and support the hypotheses of an antagonistic action of the two viruses in the 0001-4300 # 1997 SGM BEEB C. Walz and others C. Walz and others development of cervical cancer (cf. Hermonat, 1994 ; Rabreau & Schlehofer, 1995) .
Methods
Cells. Cervical carcinoma cell lines (HeLa, SW756), HeLa-derived AAV-2 DNA containing cells [HA-16 (Walz & Schlehofer, 1992) ] and immortalized human keratinocytes [HaCaT (Boukamp et al., 1988) ] were grown in Eagle's minimal essential medium (Dulbecco's modification, D-MEM ; GIBCO) supplemented with 10 % foetal calf serum (FCS) and antibiotics, at 37 mC, 5 % CO # in a humidified atmosphere.
Virus. AAV-2, propagated in HeLa cells by infection with adenovirus type 2 (Ad-2) as described (Botquin et al., 1994 ; Yakobson et al., 1987) , was purified and titrated as described previously (Botquin et al., 1994 ; Schlehofer et al., 1983 b) . Viral plasmid constructs and hybridization probes. The plasmids pAV2 (Laughlin et al., 1983) and pTAV2 , which contain the full-length AAV-2 genome, were used for transfection. HPV-16 DNA was a pUC8 plasmid in which the circular HPV-16 DNA was cloned into the BamHI site (Du$ rst et al., 1983) . Control plasmids were either pBluescript or pUC8 DNA. AAV-2 genomic inserts were prepared from pAV2 or pTAV2, and restriction fragments representing E6\E7 genes or full-length cloned HPV-16 DNA were radio-labelled with [α-$#P]dTTP (NEN Dupont) by nick translation (Rigby et al., 1977) or with [α-$#P]CTP (NEN Dupont) by the random priming technique (Feinberg & Vogelstein, 1984) .
Transfection. 80 % confluent monolayers of HeLa cells, SW756 cells, HA-16 cells or HaCaT cells, grown either in 35 mm six-well tissue culture plates or in 10 cm plastic dishes, were transfected with viral DNA (insert or uncleaved plasmid) by lipofection using Lipofectamine (Life Technologies) (2 µg plasmid DNA per 35 mm well or 8 µg plasmid DNA per 10 cm dish). Transfection took place in a humidified atmosphere at 35 mC and 3 % CO # for 24 h. After incubation, the transfection medium was discarded and D-MEM with 20 % FCS was added to the culture prior to further incubation. At the times indicated, cells were fixed for immunocytochemistry or in situ hybridization, or harvested for analysis by dispersed cell assay or for DNA extraction.
Dispersed cell assay. Cells, transfected and\or infected, and mock-treated controls were harvested by trypsinization and pooled with the culture supernatant. Aliquots were incubated with trypan blue and counted using a haemocytometer to determine cell growth and survival. From each sample, 10& cells were subjected to two freeze-thaw cycles and trapped by suction onto nitrocellulose filters for analysis of amplification of viral DNA using the dispersed cell assay described previously (Schlehofer et al., 1983 a) . Filters were hybridized with the radio-labelled probes described above, and exposed to X-ray film (Hyperfilm, Amersham).
Analysis of DNA. Southern blot analysis of high-molecular-mass cellular DNA digested with the restriction enzymes indicated was performed according to standard procedures (Sambrook et al., 1989) as described previously (Walz & Schlehofer, 1992) .
PCR. PCR for the presence of AAV DNA in fresh cervical biopsies and paraffin-embedded material was performed as described (Tobiasch et al., 1994) . Complete genomic DNA of the samples was digested with the AAV-2 non-cut restriction enzyme BglII, phenol-chloroform-extracted and used as template. The reaction was performed with Amplitaq polymerase (Perkin Elmer Cetus) in 1i reaction buffer supplemented with 1n5 mM MgCl # . The products of the reaction are 337 bp long. Immunochemistry Pre-treatment of paraffin sections. Sections (4-6 µm) were transferred onto 3-aminopropyltrithoxysilane-coated glass slides and air-dried before baking overnight at 56 mC. Preparations were deparaffinized by three changes of 100 % xylene for 10 min, overnight and again for 10 min, followed by washing in 100 % ethanol (three times for 10 min). After fixing in acetone at k20 mC for 15 min, the slides were washed twice for 10 min in 100 % ethanol and air-dried.
Preparation of culture cells for immunochemistry. For immunological analysis, cells were transfected with plasmids and\or infected with virus as indicated. After incubation for 48 h, cultures were trypsinized and suspended cells were fixed directly onto adhesion slides (Bio-Rad), washed three times with PBS and incubated in 100 % acetone for 15 min at k20 mC for permeabilization. After washing with 70 % ethanol for 24 h at 4 mC, slides were treated with decreasing alcohol concentrations at room temperature as follows k5 min 70 %, 5 min 50 %, 5 min 30 % C. Walz and others C. Walz and others Antibodies and sera. For detection of early (Rep) antigens of AAV-2, rabbit anti-Rep polyclonal serum or mouse monoclonal antibodies (Ruffing et al., 1992) were used. Secondary antibodies were swine antiIgG antibodies for the respective species of the first antibody, labelled either with fluorescein isothiocyanate (FITC) or goat antibodies, alkaline phosphatase (AP)-conjugated (Dakopatts). Antisera diluted in blocking buffer (50 µl) were applied onto the slides, covered with plastic coverslips (Parafilm) and incubated in a humid chamber at 37 mC for 45 min. After incubation, coverslips were carefully removed and preparations were washed three times for 5 min with PBS. Secondary antibodies, diluted in blocking buffer, were applied onto the slides and incubated under plastic coverslips as above. After washing in PBS, preparations labelled with FITC-conjugated second antibodies were counter-stained with DAPI (Sigma) diluted in PBS and mounted with mounting medium (glycerol\0n2 M Tris-HCl, pH 8n0 ; 9 : 1). For detection, preparations with AP-conjugated antibodies were treated with Fast Red (Sigma Fast) as recommended by the supplier. After the colour reaction, preparations were counter-stained with 10 % methyl green (Riedel-de Hae$ n) in PBS and mounted as above.
Analysis of production of infectious AAV virions.
To examine the production of infectious virus particles after co-transfection of AAV-2 DNA and HPV-16 DNA, HaCaT cells grown in six-well plates were maintained in culture for at least 5 days post-transfection. The culture medium was centrifuged at 1000 r.p.m. for 30 min and the pellets containing cellular debris were discarded. The supernatants were centrifuged at 30 000 r.p.m. for 3 h at 20 mC in an SW41 rotor (Beckman). Pellets were resuspended in approximately 30 µl of PBS. After addition of MgCl # (final concentration 2n5 mM), 10 U of DNase was added, and the suspension was incubated at 37 mC for 1 h. Two vols of cold methanol (k20 mC) were added and virus particles were spun down (as described above). Pellets were washed with cold chloroform in order to remove Lipofectamine-associated DNA, followed by high-speed centrifugation (chloroform treatment was omitted when analysing AAV-2-containing HA-16 cells, which were not transfected with AAV-2 DNA). The pellets were resuspended in PBS and inoculated on a semi-confluent monolayer of HeLa cells pre-washed with PBS and incubated for 45 min. Thereafter, Ad-2 was inoculated (30 min, 37 mC) on the culture (m.o.i. 1-10 p.f.u. per cell). Cultures were then incubated until complete Ad-2-induced CPE and analysed by the dispersed cell assay.
Rescue of AAV DNA from paraffin-embedded tissue sections (cf. Fig. 2 c) and from fresh biopsy material. Paraffin sections (4-6 µm thick) were deparaffinized and treated as described above. Airdried sections were covered with 600 µl distilled water and carefully after infection. Hybridization with labelled AAV-2 DNA revealed synthesis of AAV-2 DNA by the helper virus, demonstrating the presence of replication-competent DNA within the biopsies. DNA extracted from AAV-2-DNA-containing Ad-2-infected HA-16 cells (which contain integrated rescuable AAV-2 DNA) was used as a positive control (HA-16). HeLa cells infected with Ad-2 were the negative control (Ad-2). (c, d) Isolation of replication-competent AAV-2 DNA from paraffin-embedded tissue sections : HeLa cells were transfected with BglII-digested DNA extracted from paraffin sections as outlined in the scheme, superinfected with Ad-2, and analysed by the dispersed cell assay as described in (b). Hybridization with labelled AAV-2 DNA revealed replication of AAV-2 DNA in a few transfected cells, showing replication-competent AAV DNA in 3/4 samples. BglII-digested DNA from a paraffin-embedded section of an experimental mouse tumour induced by inoculation of AAV-2-DNA-containing HA-16 cells (Walz & Schlehofer, 1992) removed with sterile scalpels. The sample was immersed in 600 µl water, transferred into an Eppendorf tube and 300 µl of 3i lysis buffer and proteinase K (final concentration 50-100 µg\ml) were added. Highmolecular-mass cellular DNA was extracted with phenol-chloroformisoamyl alcohol (Sambrook et al., 1989) , cleaved with Bgl II (Boehringer Mannheim), precipitated, washed in 70 % ethanol and dissolved in 20 µl sterile distilled water. DNA was transfected as described above into 90 % confluent HeLa cells grown in 12-well culture plates. After incubation overnight, transfection buffer was removed and cells were infected with Ad-2 at an m.o.i. of 10 p.f.u. per cell. For analysis of the presence of AAV DNA in fresh tissue (when available), HeLa cells were transfected with genomic DNA extracted from biopsies (digested with BglII prior to transfection). After 12 h, transfection medium was removed and cells were superinfected with Ad-2 as a helper.
Cultures were maintained until complete CPE and analysed for the presence of replicated AAV DNA by the dispersed cell assay.
In situ hybridization. HA-16 cells were trypsinized 48 h after transfection with HPV-16 DNA or after infection with Ad-2, washed three times by resuspension in PBS and transferred onto adhesion slides (Bio-Rad). Cells were fixed with formaldehyde (3 % in PBS, 20 min, 4 mC), washed with PBS and then treated with proteinase K [50 mg\ml proteinase K (Boehringer Mannheim) in 50 mM Tris-HCl (pH 7n4), 10 mM EDTA, 10 mM NaCl] for 10 min at 37 mC, under a coverslip. After removal of the coverslip, samples were fixed in 0n4 % formaldehyde (5 min, 4 mC), rinsed with distilled water (5 min) and incubated in 100 % acetone (15 min, k20 mC). Thereafter, samples were incubated in 100 % ethanol (10 min, room temperature) and subsequently air-dried. Paraffin sections were deparaffinized and fixed with acetone as described above. Air-dried samples were washed twice with water (5 min) and then heated in a microwave oven (750 W, 4i3 min) in citrate buffer (9 ml 0n1 M citric acid, 41 ml 0n1 M sodium citrate made up to 500 ml with water) (compensation of evaporation by adding water at each heating step). After three washings in water, samples were treated with pepsin (4 mg\ml in 0n2 M HCl ; 37 mC, 30 min) followed by three washing steps (5 min) in water, then dehydrated in 50, 70, 90 and 100 % ethanol (3 min each step) and air-dried.
HPV-16 hybridization and subsequent detection with peroxidase were done with the Kreatech Biotechnologies Kit according to the manufacturer's protocol. Full-length AAV-2 genomic DNA was excised from the pTAV2 plasmid by digestion with XbaI and EcoRV and biotinylated using the BioNick labelling system (Gibco BRL) or labelled with digoxigenin using the DIG DNA labelling kit (Boehringer Mannheim). Labelled DNA probe (1 µg) was diluted in 600 µl TE buffer and 5 µl salmon sperm DNA (10 mg\ml), 5 µl yeast DNA (10 mg\ml) and 61 µl 3 M sodium acetate (pH 5n6) were added and thoroughly mixed. This solution was divided into two tubes, to each of which 840 µl ethanol was added and mixed. The tubes were cooled on ice shows in addition a signal at 4n6 kb (ds AAV DNA) and DNA molecules of higher molecular mass indicating the replicative for 1 h, then spun down at 14 000 r.p.m. for 30 min at 4 mC. Pellets were dissolved in 50 % formamide-2iSSC-50 mM phosphate (pH 7n0). For 10 µl hybridization solution, 2 µl of stock solution was added to 3 µl formamide-SSC-phosphate (as above) and 5 µl 20 % dextran sulphate [diluted in formamide-SSC-phosphate (as above)]. Hybridization solution (10 µl) was applied onto a prepared slide, covered with a coverslip and sealed with rubber cement. Preparations were denatured at 95 mC for 6 min, cooled on ice for 1 min and hybridized overnight in a humid chamber at 42 mC. After hybridization, the rubber cement was carefully removed and the slides were briefly immersed in 10iSSC to remove the coverslips. Then the slides were washed three times for 5 min in 50 % formamide-2iSSC at 42 mC and, subsequently, three times for 5 min in 2iSSC at room temperature. For detection, slides were washed in detection buffer (0n1 M Tris-HCl, 0n15 M NaCl) for 5 min and preincubated in 0n1 M Tris-HCl, 0n15 M NaCl, 1 % blocking reagent (Boehringer Mannheim) for 30 min at 37 mC. Detection of heterodimers in cell culture samples (HA-16 cells) was performed with FITC-conjugated streptavidin (Sigma), diluted 1 : 250 in PBS. For detection on paraffin sections, AP-conjugated streptavidin, diluted 1 : 150 in detection buffer was used. The conjugates were applied to the slides (50 µl per slide), covered with coverslips and incubated at 37 mC for 1 h in a humid chamber. Then, slides were washed [three times for 5 min in detection buffer, once in detection buffer with 100 µg\ml DAPI (Sigma)]. FITC preparations were mounted with glycerol and examined with a Leitz fluorescence microscope. Paraffin sections were washed and then preincubated in AP detection buffer (0n1 M Tris-HCl, 0n1 M NaCl, 50 mM MgCl # ; pH 9n5) for 15 min at room temperature followed by applying colour solution [45 µl NBT plus 35 µl 5-bromo-4-chloro-3-indolyl phosphate in 10 ml detection buffer (Boehringer Mannheim)]. After sealing the samples with a coverslip, they were incubated at room temperature in the dark. After removal of the coverslips, samples were briefly washed in TE buffer (10 mM Tris-HCl, 1 mM EDTA ; pH 8n0), counter-stained with methyl green as described above and mounted with glycerol.
Results

HPV and AAV DNA in biopsies of the uterine cervix
PCR analysis of fresh cervical biopsies or of sections thereof revealed the presence of DNA sequences of AAV-2 in the majority of these tissues. Confirming our earlier results (Tobiasch et al., 1994) by analysis of additional tissue samples, and in accordance with recent data from a study in the United States (Han et al., 1996) , 21 out of 27 biopsies histologically classified as normal or metaplasia were found to contain AAV-2 DNA. This proportion was lower (8\17) in biopsies from preneoplastic cervical lesions [cervical intraepithelial lesions (CIN), stage II or III or carcinoma in situ] and in cervical cancer (4\9). In most of the relevant lesions, DNA sequences of HPV were detectable by PCR whereas other helper viruses (adenoor herpesgroup viruses) were not detected (O. Malhomme, M. Rabreau, E. Armbruster-Moraes, J. R. Schlehofer & T. Dupressoir, unpublished results ; cf. Tobiasch et al., 1994) .
As shown in Fig. 1 by in situ hybridization and immunocytochemistry, respectively, AAV-2 DNA and proteins were detected in cells of the cervical epithelium [including cells typical of HPV-related lesions (Meisels et al., 1983) ]. However, confirming our previous findings (Tobiasch et al., 1994) , AAV-2 DNA was not detectable by Southern blot analysis of most cervical biopsies (Fig. 2 a) which previously had been found by PCR to contain AAV-2 DNA sequences. This is in line with the very low numbers of cells containing sufficient copies of AAV-2 DNA to be detected by in situ hybridization (Fig. 1 c, d ). In some areas of the epithelium, clusters of cells expressing Rep proteins can be visualized using specific antibodies (Fig. 1 e) . Histologically, these AAV-protein-containing cells are koilocytes, i.e. typical HPV-infected epithelial cells (Meisels et al., 1983) . In contrast, the presence of HPV DNA was demonstrated by Southern blotting, as illustrated in Fig. 2 (a) . Hybridization with HPV-16 DNA (as an example), revealed the presence of HPV-16 DNA in CIN III lesions. DNA of biopsies of metaplasia or CIN I lesions did not hybridize to the HPV-16-specific probe (Fig. 2 a) .
AAV-2 DNA present in cervical tissue could be shown to be replication-competent, since DNA extracted from fresh biopsies (7\9 cases) and transfected into HeLa cells was replicated after superinfection with adenovirus as a helper (Fig.  2 b) . This shows that genomic AAV DNA is present in genital tissue, at least in some cells. In some cases, even DNA extracted from histological sections could be demonstrated to contain replication-competent AAV-2 DNA when analysed using the technique described for Fig. 2 (c) , although less frequently and to a lesser extent than in DNA from fresh tissue (Fig. 2 c, d) .
A higher proportion of intact AAV DNA seemed to be present in fresh biopsies compared to paraffin-embedded C. Walz and others C. Walz and others material since DNA from fresh tissue was very efficiently replicated by helper virus, even when not detected by Southern blotting (cf. Fig. 2 b, c, d ).
Interaction of AAV-2 and HPV-16 in cell culture
The presence of AAV-2 and HPV in vivo within the same epithelium suggests a possible interaction of the two viruses. In the absence of helper virus, AAV-2 is known to insert its DNA into the host cell chromosomes, and the parvoviral genome can be rescued after infection with helper virus (Berns & Bohensky, 1987) . In order to test whether HPV-16 functions are able to rescue AAV-2, we transfected cells of the HeLaderived cell line HA-16, which contain AAV-2 DNA integrated into chromosome 17 (Walz & Schlehofer, 1992) , with HPV-16 DNA (since HPV-16 particles are not available : they cannot be propagated in cell culture) and analysed the replication of AAV-2 DNA. As shown by Southern blot analysis (Fig. 3 b) , AAV-2 DNA was excised from its integrated state after transfection of HPV-16 DNA, giving rise to replicative forms of AAV-2 genomes. It is noteworthy that after transfection of HPV-16 DNA, additional DNA molecules hybridizing to the AAV probe were detected, compared to rescue by adenovirus infection. Electrophoretic migration patterns obtained after Ad-2 superinfection or HPV-16 transfection differ mainly in small-sized AAV DNA molecules (2 kb), perhaps suggesting a more efficient production of single-stranded DNA progeny.
Different sizes of AAV DNA molecules were also observed when comparing DNA extracted from HA-16 cells, either superinfected with Ad-2 or transfected with HPV-16 DNA, on the one hand, and DNA extracted from HeLa cells infected with AAV-2 and adenovirus as a helper, on the other hand. These data confirm the previous observation (Walz & Schlehofer, 1992 ) that in HA-16 cells, AAV DNA is integrated at various sites. The rescue of additional AAV DNA molecules from HA-16 cells, compared to infected HeLa cells, after both Ad-2 superinfection or HPV-16 transfection, requires future detailed analyses of the AAV DNA sequences integrated in HA-16 cells and their replicative forms after rescue by helper viruses.
Replication of AAV DNA after transfection of HPV-16 DNA was confirmed by in situ hybridization (Fig. 3 a) and, in addition, expression of AAV-2 early (Rep) proteins could be observed under these conditions (Fig. 3 a) as well as production of infectious virions (Fig. 3 c) . This indicates a complete helper after co-transfection with AAV-2 and HPV-16 DNAs (jHPV t , jAAV t ). Cells transfected only by equivalent amounts of vector DNA (jvector) or Lipofectamine-treated (untransfected) , are presented as controls (middle and lower panels, respectively). (c) Production of infectious AAV-2 virions in HaCaT cells after co-transfection of AAV-2 and HPV-16 DNAs : HaCaT cells were either co-transfected with AAV-2 DNA and HPV-16 DNA (HPV-16 t jAAV t ) or transfected with AAV-2 DNA (AAV t ) or with HPV-16 DNA (HPV-16 t ). After a total time of 5 days, cell culture supernatants were collected and centrifuged to eliminate cell debris ; the supernatant was treated with methanol and then chloroform to remove Lipofectamine-associated DNA, and inoculated onto 80 % confluent HeLa cells. After incubation for 12 h, the inoculum was removed and the cells were infected with Ad-2 helper virus (m.o.i. 10 p.f.u. per cell) and incubated. After reaching complete Ad-2-induced CPE, cells were transferred onto nylon membranes and analysed by the dispersed cell assay with radio-labelled AAV-2 DNA for amplified AAV-2 DNA. The positive hybridization signal indicates the presence of infectious AAV-2 virions in the supernatant of AAV-2-and HPV-16-transfected cells.
effect of HPV-16 for AAV-2 which, under the transfection conditions used here, was nearly as efficient as superinfection with adenovirus.
In order to substantiate the helper functions of HPV-16 for AAV-2 replication, we transfected HPV-16 DNA into cells of the cervical carcinoma cell lines HeLa and SW756, and of the human keratinocyte cell line HaCaT. In addition, these cells were transfected with AAV-2 DNA or infected with AAV-2 virions. Provided that AAV-2 DNA was transfected (or AAV-2 virus was inoculated) prior to (12-24 h) or simultaneously with transfection of HPV-16 DNA, replication of AAV-2 DNA could be demonstrated by Southern blot analysis (Fig.  4 a, for HaCaT cells as an example) and transcripts of AAV-2 were detectable by Northern blot analysis (data not shown), confirming the helper effect of HPV-16 functions for the replication of AAV-2.
In differentiation-competent keratinocytes (HaCaT), coexpression of AAV-2 and HPV-16 led to reduction of cell growth, and eventually, after 5 days, to CPE ( Fig. 4 b) , which was not observed in cervical carcinoma cell lines. (However, cell killing was less efficient when compared to adenovirusinduced CPE.) In addition, the supernatant of HaCaT cells cotransfected by HPV-16 and AAV-2 DNA was found to contain infectious AAV-2 (Fig. 4 c) .
Discussion
The role of infection with HPV in the development of neoplastic lesions (CIN) within the epithelium of the uterine cervix and a causal relationship of specific HPV types (notably types 16, 18, 31 and 33) with cervical and other genital cancers has been unequivocally established (reviewed in : Mun4 oz et al., 1994 ; zur Hausen, 1991) .
Recently, we reported the presence of DNA of the helpervirus-dependent parvovirus AAV-2 in the majority of biopsies of the uterine cervix (Tobiasch et al., 1994) . This finding was recently confirmed by analysis of cervical brushings, in a study from the United States (Han et al., 1996) . AAV infect humans early in childhood (Blacklow et al., 1971 ; Mayor et al., 1976) and may persist in specific tissues lifelong (Cukor et al., 1984 ; Grossman et al., 1992) .
In this study, we present evidence that the genital HPV type 16 can act as a helper for the replication of the tumoursuppressive, defective human parvovirus AAV-2. This adds C. Walz and others C. Walz and others papillomaviruses to the known helper viruses for AAV, and the co-localization of the two viruses suggests that HPV might be a natural helper, at least in genital infections.
AAV has been demonstrated to exert inhibitory effects on mutagenesis (Schlehofer & Heilbronn, 1990) , and on carcinogen-or virus-mediated DNA amplification Schlehofer et al., 1983 b ; Schmitt et al., 1989) . In addition, in the absence of helper viruses, AAV DNA is readily integrated (at least in cell culture) into the cellular genome (Kotin et al., 1990 ; Samulski, 1993 ; Samulski et al., 1991 ; Walz & Schlehofer, 1992) , and cells containing AAV DNA are more sensitive to genotoxic events (Walz & Schlehofer, 1992 ; Winocour et al., 1992) . Such events are postulated to be involved, in addition to infection with HPV, in the process of malignant transformation of the cervical tissue (zur Hausen, 1991) .
Our data indicate that expression of the HPV E6\E7 proteins is not sufficient to allow AAV-2 DNA replication since this is not observed in AAV-2-infected HeLa or SW756 cervical carcinoma-derived cells, which express HPV-18 E6\E7 proteins [similar results were obtained with cells containing HPV-16 DNA (SiHa, CaSki) ; unpublished]. The contiguity of other early genes of HPV [notably E1\E2, which are involved in replication of HPV (Sverdrup & Khan, 1994) ] is disrupted in most cancer cells (Schneider-Ga$ dicke & Schwarz, 1986 ; Schwarz et al., 1985) due to the integration of the HPV genome (zur Hausen, 1994) . It is to be assumed, therefore, that HPV genes other than or in addition to E6\E7 are necessary for helping AAV-2 replication.
Adeno-associated parvoviruses are known for their oncosuppressive properties (reviewed in : Schlehofer, 1994 ) and antibodies to AAV were found to be less prevalent in sera from cervical cancer patients compared to control women (GeorgFries et al., 1984 ; Mayor et al., 1976) . The detection of DNA of the tumour-suppressive AAV in normal genital tissue of a large proportion of women might indicate an AAV-mediated protection from malignant transformation. As evident from in situ hybridization and from previous PCR data (Tobiasch et al., 1994) only a few cells of the uterine cervix appear to be infected with AAV, and non-infected cells may give rise to HPV-related tumours when HPV-infected (zur Hausen, 1991). Since AAV DNA was less frequently found in biopsies from premalignant or malignant lesions of the cervix compared to the high prevalence in normal cervical tissue (cf. above : ' Results ') it is conceivable that in malignant lesions, detection by PCR of AAV DNA might be a result of non-transformed cervical cells also present in the biopsies.
The presence of a virus with tumour-suppressive properties in cervical tissue suggests an antagonistic effect of AAV on transforming functions of HPV. Indeed, in vitro studies have shown that the early (Rep) proteins of AAV-2 interfere with the transforming functions of BPV and of HPV type 16 or type 18 E6\E7 oncoproteins (Hermonat, 1989 (Hermonat, , 1994 Ho$ rer et al., 1995) .
Whether AAV-2 functions interfere with the P *( promoter of HPV-16, which regulates E6\E7 production, or with HPV or cellular proteins which regulate this promoter (Chan et al., 1989 (Chan et al., , 1990 Gloss et al., 1987 ; Swift et al., 1987) is currently under investigation.
The co-localization of DNA of AAV and HPV in cervical tissues suggests a biological interaction of both viruses in vivo. AAV is able to induce differentiation-associated processes, to down-regulate expression of genes involved in proliferation (Klein-Bauernschmitt et al., 1992) , and to perturb the cell cycle (Bantel-Schaal & Sto$ hr, 1992 ; Winocour et al., 1988) . HPV needs a differentiating epithelium for its own ' maturation ', i.e. expression of papillomavirus genes and replication of viral DNA depend on epithelial differentiation (Du$ rst et al., 1992 ; Stoler et al., 1989) . It is tempting to speculate that HPV and AAV may assist each other. AAV may provide stimulation of differentiation processes and HPV possibly triggers functions necessary for AAV gene expression and replication. Induction of differentiation and tissue maturation, mediated by AAV functions, may give rise to expression of papillomavirus genes in the upper layers of the epithelium thereby enhancing the probability of production of papilloma virions.
On the other hand, infection with HPV of cells harbouring AAV DNA may perturb establishment of the transforming [i.e. proliferative as opposed to replicative (Crook et al., 1989) ] functions since increased expression of the HPV-16 E6\E7 genes is essential for cell immortalization (Mu$ nger et al., 1989) and seems to be correlated with enhanced cell proliferation (cf. zur Hausen, 1994) .
In human keratinocytes (HaCaT cells) which are capable of differentiation, expression of HPV-16 genes together with AAV-2 genes was found to be accompanied by CPE. In vivo, this cytotoxicity may account for the enhanced sensitivity towards genotoxic treatment of AAV-infected or AAV-DNAcontaining cells (Walz & Schlehofer, 1992 ; Walz et al., 1992) . Hence, cells containing transforming papillomaviruses that are initiated by carcinogens may have a reduced chance of survival when containing AAV DNA as well.
HPV was reported to be more frequently detectable in cervical swabs or biopsies during pregnancy (Schneider et al., 1987) . Interestingly, large amounts of AAV DNA were detected (by Southern blot analysis) in tissue from early miscarriage (Tobiasch et al., 1994) . Since in addition, HPV DNA could be detected in material from early abortion (Armbruster et al., 1994) , it is tempting to speculate that hormonal influences together with HPV functions may reactivate AAV persisting in the mucosa of the uterus. Reactivation of persisting AAV is also suggested by the finding of a higher prevalence of IgM-type serum antibodies to AAV-2 in patients with CIN lesions and in women with spontaneous miscarriage (Tobiasch et al., 1994) .
Improvement of diagnostic procedures to detect AAV in biopsies and serological tests are needed to evaluate whether indeed previous AAV infections reduce the cervical cancer risk BEFA for patients infected with high-risk papillomaviruses. More virological and molecular studies in cancer cells are required to address the question of a possible use of AAV in cancer prevention (e.g. by inducing killing of HPV-infected cells and\or by favouring down-regulation of E6\E7 in preneoplastic lesions). In addition, the apparent ' natural ' infection of cervical tissue by AAV-2 may be useful for targeting cervical cells when envisaging the transduction of (cancer) therapy genes using AAV-2 vectors.
